Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5365)
All Articles published online
|
Publishing Process of This Article
|
May 26, 2024 (publication date) through Nov 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Mondal S, Pramanik S, Khare VR, Fernandez CJ, Pappachan JM. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives. World J Cardiol 2024; 16(5): 240-259 [PMID: 38817648 DOI: 10.4330/wjc.v16.i5.240] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Mondal S, Pramanik S, Khare VR, Fernandez CJ, Pappachan JM. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives. World J Cardiol 2024; 16(5): 240-259 [PMID: 38817648 DOI: 10.4330/wjc.v16.i5.240] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v16/i5/240.htm |
| Number | Citing Articles |
| 1 |
Takefumi Kishimori, Takao Kato, Atsuyuki Wada, Akira Tani, Ryosuke Yamaji, Jumpei Koike, Yoshihiro Iwasaki, Takahiro Matsumoto, Takafumi Yagi, Masaharu Okada. Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes. BMJ Open Diabetes Research & Care 2025; 13(6): e005364 doi: 10.1136/bmjdrc-2025-005364
|
| 2 |
Xiangling Duan, Xiaomeng Zhang, Bao Sun. The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02750-4
|
| 3 |
Xinyue Zhang, Yanxia Zhang, Jiayu Wang, Zhijia Tang. Sodium-glucose cotransporter 2 inhibitors in the treatment of heart failure patients: A systematic review and meta-analysis of cost-utility studies. Archives of Gerontology and Geriatrics 2025; 133: 105809 doi: 10.1016/j.archger.2025.105809
|
| 4 |
Elena Y. Rykova, Vadim V. Klimontov, Elena Shmakova, Anton I. Korbut, Tatyana I. Merkulova, Julia Kzhyshkowska. Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages. International Journal of Molecular Sciences 2025; 26(4): 1670 doi: 10.3390/ijms26041670
|
| 5 |
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, V Jagadeeshwaran, Sriram D K. Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations. Current Research in Translational Medicine 2025; 73(2): 103496 doi: 10.1016/j.retram.2025.103496
|
| 6 |
Samar Abed Alharbi, Amal Ahmad Alsubaiei, Ali Hussain Alkhalifah, Abdulrahman Abdulaziz Alshehri, Shoog Soliman Alhaggas, Shahad Marwan Alhuthli, Yousef Hassan Alfaqih, Wed Ziyad Alnajjar, Ghaida Abdulla Alshaban, Mahmood Sameer Ahmed, Abdulkarem Sarhan Alqarni. The role of SGLT2 inhibitors in protecting cardiovascular health: beyond glycaemic control. International Journal Of Community Medicine And Public Health 2025; doi: 10.18203/2394-6040.ijcmph20250050
|
| 7 |
Saheed E. Sanyaolu, Diana O. Wilson, Blessing A. Oguntolu, Mautin S. Salako, Rukayat O. Adeyemi. Current Evidence on the Clinical Management of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. Premier Journal of Cardiology 2025; doi: 10.70389/PJC.100011
|
| 8 |
Rebecca Ayoti, Zahid Khan, Gideon Mlawa, Animesh Gupta. Assessing the Effectiveness and Safety of Combination Diuretic Therapy in Heart Failure: A Systematic Review and Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.72118
|